Class action lawsuit filed against Zoetis over alleged securities fraud after profit guidance cut.

Pomerantz LLP has filed a class action lawsuit against Zoetis Inc., alleging securities fraud and other unlawful practices following the company's announcement of a profit guidance cut for 2026. Zoetis reported flat net income of $601 million for Q1 2026 and lowered its full-year profit forecast, citing a challenging market with reduced veterinary visits and softer demand. As a result, Zoetis's stock price dropped 21.5% on the day of the announcement. Investors who purchased Zoetis securities during the class period have until July 27, 2026, to join the lawsuit or seek lead plaintiff status.